Temporal and spatial dynamics of nrf2-antioxidant response elements mediated gene targets in cortex and hippocampus after controlled cortical impact traumatic brain injury in mice

Journal of Neurotrauma

Volumn 31, Issue 13, 2014, Pages 1194-1201

  Miller, Darren M ^a   Wang, Juan A ^a   Buchanan, Ashley K ^a   Hall, Edward D ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

4 hydroxy 2 nonenal; gene expression; lipid peroxidation; Nrf2; oxidative damage; traumatic brain injury

Indexed keywords

CATALASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE REDUCTASE; HEME OXYGENASE 1; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE QUINONE OXIDOREDUCTASE 1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; NFE2L2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CELL PROTECTION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENE TARGETING; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PEROXIDATION; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TEMPORAL ANALYSIS; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING; ANIMAL; ANTIOXIDANT RESPONSIVE ELEMENT; BIOSYNTHESIS; BRAIN INJURY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TIME;

ANIMALS; ANTIOXIDANT RESPONSE ELEMENTS; BRAIN INJURIES; CEREBRAL CORTEX; GENE TARGETING; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MICE; NF-E2-RELATED FACTOR 2; TIME FACTORS;

EID: 84903834531     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.3218     Document Type: Article

References (46)

1. Thurman, D.J., Alverson, C., Dunn, K.A., Guerrero, J., and Sniezek, J.E. (1999). Traumatic brain injury in the United States: A public health perspective. J. Head Trauma Rehabil. 14, 602-615
2. Deng, Y., Thompson, B.M., Gao, X., and Hall, E.D. (2007). Temporal relationship of peroxynitrite-induced oxidative damage, calpainmediated cytoskeletal degradation and neurodegeneration after traumatic brain injury. Exp. Neurol. 205, 154-165
3. Singh, I.N., Sullivan, P.G., Deng, Y., Mbye, L.H., and Hall, E.D. (2006). Time course of post-Traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: Implications for neuroprotective therapy. J. Cereb. Blood Flow Metab. 26, 1407-1418
4. Thompson, S.N., Gibson, T.R., Thompson, B.M., Deng, Y., and Hall, E.D. (2006). Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice. Exp. Neurol. 201, 253-265
5. Hall. E.D., and Braughler, J.M. (1993). Free radicals in CNS injury. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 71, 81-105
6. Hall, E.D., McCall, J.M., and Means, E.D. (1994). Therapeutic potential of the lazaroids (21-Aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv. Pharmacol. 28, 221-268
7. Hall, E.D., Andrus, P.K., Yonkers, P.A., Smith, S.L., Zhang, J.R., Taylor, B.M., and Sun, F.F. (1994). Generation and detection of hydroxyl radical following experimental head injury. Ann. N. Y. Acad. Sci. 738, 15-24
8. Smith, S.L., Andrus, P.K., Zhang, J.R., and Hall, E.D. (1994). Direct measurement of hydroxyl radicals, lipid peroxidation, and blood-brain barrier disruption following unilateral cortical impact head injury in the rat. J. Neurotrauma 11, 393-404
9. Ansari, M.A., Roberts, K.N., and Scheff, S.W. (2008). A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI. J. Neurotrauma 25, 513-526
10. Ansari, M.A., Roberts, K.N., and Scheff, S.W. (2008). Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury. Free Radic. Biol. Med. 45, 443-452
11. Kontos, H.A., and Povlishock, J.T. (1986). Oxygen radicals in brain injury. Cent. Nerv. Syst. Trauma 3, 257-263
12. Kontos, H.A., and Wei, E.P. (1986). Superoxide production in experimental brain injury. J. Neurosurg. 64, 803-807
13. Kensler, T.W., Wakabayashi, N., and Biswal, S. (2007). Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47, 89-116
14. Lindner, M.D., Plone, M.A., Cain, C.K., Frydel, B., Francis, J.M., Emerich, D.F., and Sutton, R.L. (1998). Dissociable long-Term cognitive deficits after frontal versus sensorimotor cortical contusions. J. Neurotrauma 15, 199-216
15. Chan, J.Y., Han, X.L., and Kan, Y.W. (1993). Isolation of cDNA encoding the human NF-E2 protein. Proc. Natl. Acad. Sci. U. S. A. 90, 11366-11370
16. Itoh, K.N., Wakabayashi, Y., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D., and Yamamoto, M. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-Terminal Neh2 domain. Genes Dev. 13, 76-86
17. Moi, P., Chan, K., Asunis, I., Cao, A., and Kan, Y.W. (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. U. S. A. 91, 9926-9930
18. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., and Yamamoto, M. (2004). Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24:7130-7139
19. Kobayashi A., Kang MI, Watai Y, Tong KI, Shibata T, Uchida K, and Yamamoto M. (2006). Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell Biol. 26, 221-229
20. Tong, K.I., Kobayashi, A., Katsuoka, F., and Yamamoto, M. (2006). Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism. Biol. Chem. 387, 1311-1320
21. Jain, A.K., Bloom, D.A., and Jaiswal, A.K. (2005). Nuclear import and export signals in control of Nrf2. J. Biol. Chem. 280, 29158-29168
22. Johnson, J.A., Johnson, D.A., Kraft, A.D., Calkins, M.J., Jakel, R.J., Vargas, M.R., and Chen, P.C. (2008). The Nrf2-ARE pathway: An indicator and modulator of oxidative stress in neurodegeneration. Ann. N. Y. Acad. Sci. 1147, 61-69
23. Calkins, M.J., Jakel, R.J., Johnson, D.A., Chan, K., Kan, Y.W., and Johnson, J.A. (2005). Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc. Natl. Acad. Sci. U. S. A. 102, 244-249
24. Calkins, M.J., Vargas, M.R., Johnson, D.A., and Johnson, J.A. (2010). Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition. Toxicol. Sci. 115, 557-568
25. Innamorato, N.G., Rojo, A.I., Garcia-Yague, A.J., Yamamoto, M., de Ceballos, M.L., and Cuadrado, A. (2008). The transcription factor Nrf2 is a therapeutic target against brain inflammation. J. Immunol. 181, 680-689
26. Rojo, A.I, Innamorato, N.G, Martin-Moreno, A.M., de Ceballos, M.L., Yamamoto, M., and Cuadrado, A. (2010). Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia 58, 588-598
27. Li, J., Johnson, D., Calkins, M., Wright, L., Svendsen, C., and Johnson, J. (2005). Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol. Sci. 83, 313-328
28. Vargas, M.R., Johnson, D.A., Sirkis, D.W., Messing, A., and Johnson, J.A. (2008). Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J. Neurosci. 28, 13574-13581
29. Zhao, J., Kobori, N., Aronowski, J., and Dash, P.K. (2006). Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci. Lett. 393, 108-112
30. Zhao, X., Sun, G., Zhang, J., Strong, R., Dash, P.K., Kan, Y.W., Grotta, J.C., and Aronowski, J. (2007). Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke 38, 3280-3286
31. Innamorato, N.G., Jazwa, A., Rojo, A.I., Garcia, C., Fernandez-Ruiz, J., Grochot-Przeczek, A., Stachurska, A., Jozkowicz, A., Dulak, J., and Cuadrado, A. (2010). Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1. PLoS One 5, e11838
32. Kraft, A.D., Resch, J.M., Johnson, D.A., and Johnson, J.A. (2007). Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1. Exp. Neurol. 107-117
33. Son, T.G., Camandola, S., Arumugam, T.V., Cutler, R.G., Telljohann, R.S., Mughal, M.R., Moore, T.A., Luo, W., Yu, Q.S., Johnson, D.A., Johnson, J.A., Greig, N.H., and Mattson, M.P. (2010). Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia. J. Neurochem. 112, 1316-1326
34. Jin, W., Wang, H., Yan, W., Zhu, L., Hu, Z., Ding, Y., and Tang, K. (2009). Role of Nrf2 in protection against traumatic brain injury in mice. J. Neurotrauma 26, 131-139
35. Jin, W., Wang, H., Ji, Y., Zhu, L., Yan, W., Qiao, L., and Yin, H. (2009). Genetic ablation of Nrf2 enhances susceptibility to acute lung injury after traumatic brain injury in mice. Exp. Biol. Med. 234, 181-189
36. Zhao, J., Moore, A.N., Redell, J.B., and Dash, P.K. (2007). Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J. Neurosci. 27, 10240-10248
37. Zhao, J., Moore, A.N., Clifton, G.L., and Dash, P.K. (2005). Sulforaphane enhances aquaporin-4 expression and decreases cerebral edema following traumatic brain injury. J. Neurosci. Res. 82, 499-506
38. Dash, P.K., Zhao, J., Orsi, S.A., Zhang, M., and Moore, A.N. (2009). Sulforaphane improves cognitive function administered following traumatic brain injury. Neurosci. Lett. 460, 103-107
39. Satoh, T.K., Kosaka, K., Itoh, K., Kobayashi, A., Yamamoto, M., Shimojo, Y., Kitajima, C., Cui, J., Kamins, J., Okamoto, S., Izumi, M., Shirasawa, T., and Lipton S.A. (2008). Carnosic acid, a catechol-Type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-Alkylation of targeted cysteines on Keap1. J. Neurochem. 104, 1116-1131
40. Hall, E.D., Wang, J.A., and Miller, D.M. (2012). Relationship of nitric oxide synthase induction to peroxynitrite-mediated oxidative damage during the first week after experimental traumatic brain injury. Exp. Neurol. 238, 176-182
41. Miller, D.M., Singh, I.N., Wang, J.A., and Hall, E.D. (2013). Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radic. Biol. Med. 57, 1-9
42. Bains, M., and Hall, E.D. (2012). Antioxidant therapies in traumatic brain and spinal cord injury. Biochim. Biophys. Acta 1822, 675-684
43. Cheng, Z.G., Zhang, G.D., Shi, P.Q., Du, B.S. (2013). Expression and antioxidation of Nrf2/ARE pathway in traumatic brain injury. Asian Pac. J. Trop. Med., 6, 305-310
44. Dowell, J.A., and Johnson, J.A. (2013). Mechanisms of Nrf2 protection in astrocytes as identified by quantitative proteomics and siRNA screening. PLoS One 8, e70163
45. Smith, C.D., Carney, J.M., Starke-Reed, P.E., Oliver, C.N., Stadtman, E.R., Floyd, R.A., and Markesbery, W.R. (1991). Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 88, 10540-10543
46. Andrus, P.K., Fleck, T.J., Gurney, M.E., and Hall, E.D. (1998). Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 71, 2041-2048